Steven Cohen’s Candel Therapeutics CADL Stock Holding History
Bought
Maintained
Sold
Other funds holding CADL
ACA
SVCM
Steven Cohen's CADL Position: Q3 2026 in Review
Steven Cohen increased its Candel Therapeutics (CADL) stake by 159% in Q3 2026, buying an estimated $2.28M and bringing the position to 335,108 shares worth $3.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2036.
Steven Cohen first reported a position in CADL in Q2 2022 and has held it in 5 quarters since. 140 funds tracked by Wall St. Rank hold CADL as of Q3 2026.
- Steven Cohen held 335,108 shares of Candel Therapeutics worth $3.5M as of Q3 2026.
- Steven Cohen bought 205,925 Candel Therapeutics shares in Q3 2026, an estimated $2.28M.
- Candel Therapeutics made up ﹤0.01% of Steven Cohen's portfolio in Q3 2026, its #2036 holding.
- Steven Cohen first reported a position in Candel Therapeutics in Q2 2022 and has held it in 5 quarters since.
- 140 funds tracked by Wall St. Rank held Candel Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.